Remembering Alison Friedman: A champion for access, equity, and hope
The Colorectal Cancer Alliance mourns the passing of Alison Kiehl Friedman, a tireless advocate, policy leader, board member, mom, wife, and beloved member of our community, whose impact will continue to shape our mission for years to come.
Diagnosed with stage IV colorectal cancer at just 43 years old, Alison faced the unimaginable with clarity and conviction. Even as she navigated her own treatment, she was determined to confront not only cancer itself but also the systemic barriers that too often determine who gets care — and who doesn’t. Alison understood that survival shouldn’t depend on privilege, proximity, or luck.
Through her insight, leadership, and unwavering determination, Alison helped focus the Alliance’s advocacy work on healthcare access and federal funding for colorectal cancer research and prevention. She recognized that saving lives required not only advancing science, but also ensuring every patient could reach it. Her perspective helped guide the Alliance as we deepened our commitment to equity in screening, diagnosis, and treatment across communities.
Beyond her influence in policy and strategy, Alison was known for her warmth, generosity, and thoughtfulness. She built coalitions across professional and personal networks, uniting people around a shared belief: that access to life-saving care is a right, not a privilege.
Alison’s life and legacy remind us what it means to be both fierce and kind, both visionary and compassionate. Her work lives on in every patient who gains access to care, every voice lifted for equity, and every step taken toward a future free of colorectal cancer.
Alison and her husband, Mark, were co-chairs of the Alliance’s Blue Hope Bash in 2024, and Alison had recently joined the Board of Directors. Alison and Mark established the Access Fund to support efforts to ensure all colorectal cancer patients, regardless of their background or financial situation, can access the necessary care and cutting-edge treatment options needed to improve their chances of survival.
We extend our deepest condolences to Alison’s family, friends, and all who were touched by her courage.
Top resources
FDA Clears Way for Colorectal Cancer Clinical Trial Led by Dr. Christopher Lieu
The U.S. Food and Drug Administration has given researchers at the University of Colorado Anschutz Medical Campus permission to begin a clinical trial of CAR T-cell therapy for people with advanced colorectal cancer who have already tried the standard treatments without lasting success.
He almost skipped the colonoscopy that saved his life
Andy said his lifestyle made it easier to ignore the blood in the stool, a symptom of colorectal cancer. But the “mirage of invincibility,” as he called it, was about to vanish.
Alliance Appoints New Members to Board of Directors
Each of the four appointees to the Alliance's Board brings unique professional expertise and a personal commitment to the organization's mission to end colorectal cancer in our lifetime.